Evaluation of 200 mg of Rituximab Every 6 Months as Maintenance Treatment of Rituximab-treated Patients With Rheumatoid Arthritis

Clinical trial NCT06906549 · RECRUITING

Trial details

NCT number: NCT06906549
Sponsor: University Hospital, Strasbourg, France
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Rheumatoid Arthritis (RA)Rituximab (RTx)

Start date: 2025-07-11
Primary completion: 2026-07-01
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.